ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,180.74
1.03%
Dow Jones
38,852.27
0.46%
US Dollar vs MXN
16.8889
0.02%
Brent Oil
83.465
-0.01%
Bitcoin
63,650.22
0.77%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Pliant Therapeutics Inc (PLRX)

  7. Pliant Therapeutics Inc (PLRX) Noticias

PLRX Pliant Therapeutics Inc

13.79
-0.19 (-1.36%)
06 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Pliant Therapeutics Inc PLRX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.19 -1.36% 13.79 18:58:03
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
14.09 13.71 14.33 13.79 13.98
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/5/202415:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202415:11EDGAR2Form 8-K - Current report
06/5/202415:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
06/5/202405:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/5/202407:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
02/4/202407:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
27/3/202409:23GLOBEPliant Therapeutics Announces Upcoming Presentations at the..
12/3/202406:30GLOBEPliant Therapeutics Announces Accelerated Bexotegrast..
27/2/202415:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202415:06EDGAR2Form 8-K - Current report
27/2/202415:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
26/2/202407:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
14/2/202419:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202407:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202407:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
05/2/202406:31EDGAR2Form 8-K - Current report
04/2/202414:29GLOBEPliant Therapeutics Announces Positive Safety and..
24/1/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202407:00GLOBEPliant Therapeutics to Participate in the 42nd Annual J.P...
13/11/202315:30GLOBEPliant Therapeutics Presentations at The Liver Meeting® 2023..
09/11/202315:11EDGAR2Form 8-K - Current report
09/11/202315:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
08/11/202307:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
06/11/202307:00GLOBEPliant Therapeutics Presentations at the Annual Meeting of..
31/10/202315:03GLOBEPliant Therapeutics Announces Three Presentations at the..
19/10/202307:00GLOBEPliant Therapeutics INTEGRIS-PSC Phase 2a Interim Data..
16/10/202315:05GLOBEPliant Therapeutics Appoints S. Mishima Gerhart as Chief..
03/10/202315:53EDGAR2Form 8-K - Current report
26/9/202306:34EDGAR2Form 8-K - Current report
26/9/202306:30GLOBEPliant Therapeutics Announces Positive Safety and..
25/9/202315:05GLOBEPliant Therapeutics to Host Investor Call and Webcast to..
15/9/202307:00GLOBEPliant Therapeutics Appoints Minnie Kuo as Chief Development..
11/9/202307:00GLOBEPliant Therapeutics Announces Presentations at the European..
30/8/202307:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
28/8/202315:05GLOBEPliant Therapeutics Announces Three Upcoming Presentations..
09/8/202315:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:05EDGAR2Form 8-K - Current report
09/8/202315:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
09/8/202307:00GLOBEPliant Therapeutics Announces Initiation of BEACON-IPF, a..
25/7/202307:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
21/7/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202315:06EDGAR2Form 144 - Report of proposed sale of securities
19/7/202319:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202319:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
PLRX
Pliant Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados